The utility of anti-müllerian hormone in the diagnosis and prediction of loss of ovarian function following chemotherapy for early breast cancer

Richard Anderson; J Mansi; R E Coleman; D J A Adamson; Robert Leonard

doi:10.1016/j.ejca.2017.10.001

The utility of anti-müllerian hormone in the diagnosis and prediction of loss of ovarian function following chemotherapy for early breast cancer

Richard Anderson, J Mansi, R E Coleman, D J A Adamson, Robert Leonard

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	European Journal of Cancer
Early online date	5 Nov 2017
DOIs	https://doi.org/10.1016/j.ejca.2017.10.001
Publication status	Published - Dec 2017

Access to Document

10.1016/j.ejca.2017.10.001

1-s2.0-S0959804917313412-mainFinal published version, 636 KBLicence: CC BY

http://www.sciencedirect.com/science/article/pii/S0959804917313412

1 Active

MRC Centre for Reproductive Health at the University of Edinburgh
Pollard, J.
MRC
12/09/16 → 11/09/22
Project: Research

Cite this

@article{b8b9dcac60e04bbda6139374f49075ef,

title = "The utility of anti-m{\"u}llerian hormone in the diagnosis and prediction of loss of ovarian function following chemotherapy for early breast cancer",

author = "Richard Anderson and J Mansi and Coleman, {R E} and Adamson, {D J A} and Robert Leonard",

year = "2017",

month = dec,

doi = "10.1016/j.ejca.2017.10.001",

language = "English",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "PERGAMON-ELSEVIER SCIENCE LTD",

}

TY - JOUR

T1 - The utility of anti-müllerian hormone in the diagnosis and prediction of loss of ovarian function following chemotherapy for early breast cancer

AU - Anderson, Richard

AU - Mansi, J

AU - Coleman, R E

AU - Adamson, D J A

AU - Leonard, Robert

PY - 2017/12

Y1 - 2017/12

U2 - 10.1016/j.ejca.2017.10.001

DO - 10.1016/j.ejca.2017.10.001

M3 - Article

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

ER -

The utility of anti-müllerian hormone in the diagnosis and prediction of loss of ovarian function following chemotherapy for early breast cancer

Access to Document

Projects

MRC Centre for Reproductive Health at the University of Edinburgh

Cite this